Insider · CIK 0001950551

Gamelin Erick

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001950551

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-18	ACRVAcrivon Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−400 sh	$2.01	−$804	52,592
2026-05-18	ACRVAcrivon Therapeutics, Inc.A Award	Chief Development Officer	AAward	+38.6K sh	—	—	52,992
2026-05-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−404 sh	$1.92	−$775.68	14,408
2026-03-01	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+94.9K sh	—	—	94,946
2026-02-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−471 sh	$1.63	−$767.73	14,812
2025-11-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−403 sh	$2.24	−$902.72	15,283
2025-08-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−403 sh	$1.39	−$560.17	15,686
2025-05-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−403 sh	$1.14	−$459.42	16,089
2025-03-01	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+78.1K sh	—	—	78,078
2025-02-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−469 sh	$5.42	−$2,541.98	16,492
2024-11-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−402 sh	$7.92	−$3,183.84	16,961
2024-08-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−402 sh	$7.02	−$2,822.04	17,363
2024-05-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−402 sh	$8.36	−$3,360.72	17,765
2024-03-01	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+45K sh	—	—	45,045
2024-02-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−468 sh	$3.40	−$1,591.2	18,167
2023-11-14	ACRVAcrivon Therapeutics, Inc.F Tax Payment	Chief Development Officer	FTax Payment	−1,395 sh	$5.08	−$7,086.6	18,635
2022-11-14	ACRVAcrivon Therapeutics, Inc.A Award	Chief Development Officer	AAward	+20K sh	—	—	20,030
2022-11-14	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+60.1K sh	—	—	60,090

Recent filings

Accepted (ET)
Aug 204
Gamelin Erick0000905148-26-003838
SEC(opens sec.gov)
May 204
Gamelin Erick0000905148-26-002551
SEC(opens sec.gov)
May 184
Gamelin Erick0000905148-26-002500
SEC(opens sec.gov)
Mar 34
Gamelin Erick0000905148-26-001117
SEC(opens sec.gov)
Feb 184
Gamelin Erick0000905148-26-000936
SEC(opens sec.gov)
Nov 184
Gamelin Erick0000905148-25-004129
SEC(opens sec.gov)
Aug 184
Gamelin Erick0000905148-25-003041
SEC(opens sec.gov)
May 164
Gamelin Erick0000905148-25-001822
SEC(opens sec.gov)
Mar 44
Gamelin Erick0000905148-25-000836
SEC(opens sec.gov)
Feb 194
Gamelin Erick0000905148-25-000727
SEC(opens sec.gov)
Nov 274
Gamelin Erick0000905148-24-003291
SEC(opens sec.gov)
Nov 184
Gamelin Erick0000905148-24-003225
SEC(opens sec.gov)
Aug 164
Gamelin Erick0000905148-24-002279
SEC(opens sec.gov)
May 164
Gamelin Erick0000905148-24-001487
SEC(opens sec.gov)
Feb 164
Gamelin Erick0000905148-24-000762
SEC(opens sec.gov)
Nov 164
Gamelin Erick0000905148-23-001474
SEC(opens sec.gov)
Nov 164
Gamelin Erick0001209191-22-057400
SEC(opens sec.gov)

Companies

Acrivon Therapeutics, Inc.Chief Development OfficerACRV

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472